In adults, ASPS has a propensity for the lower extremities but can arise in unusual locations such as the mediastinum, breast, urinary bladder, gastrointestinal tract, bone, and female genital tract. In children, ASPS may arise in the head and neck, particularly the orbit and tongue [2, [6] [7] [8] . The diagnosis of ASPS relies on histopathology, immunohistochemistry, and molecular features. Histologically these tumors have a uniform pattern characterized by a pseudoalveolar or organoid arrangement of polygonal tumor cells separated by fibrovascular septa and delicate capillary-sized vascular channels [9, 10] . A characteristic unbalanced translocation, der(17)t(X;17) (p11;q25), results in the formation of an ASPL-TFE3 fusion protein. This translocation is seen almost ex- is a rare solid malignancy that accounts for fewer than 1% of all soft-tissue sarcomas [1] . It occurs most commonly in adolescents and young adults and has a slight female predominance [2] [3] [4] . Typically, ASPS is a slow-growing tumor and often comes to clinical attention late in the disease process. Approximately 65% of adults and 30% of children present with metastatic disease in the lungs, brain, bone, or lymph nodes. Metastases also occur decades after resection of the primary tumor even in the absence of local recurrence [2, 5] . The prognosis of patients with ASPS is poor. In a large study by Lieberman and colleagues [5] , survival of 102 subjects decreased from 87% at 2 years to 18% at 20 years.
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clusively in ASPS and some pediatric renal cell carcinomas [10] and rarely in periendothelial epithelioid cell tumors [11] . An antibody directed against the C-terminus of the TFE3 protein is a highly sensitive and specific marker for ASPS. Investigators have suggested that the increased incidence of ASPS in females is related to their two X chromosomes, which doubles the probability of this translocation as compared with males [10] .
The mainstay of treatment of ASPS is complete surgical resection of the primary tumor and radiotherapy for microscopic residual disease at the primary site. In adults, ASPS is known to be resistant to standard chemotherapy. Because of the rarity of this tumor in pediatric patients, the role of chemotherapy in this patient population has not been clearly defined. The Children's Oncology Group (COG) recently conducted a large multiinstitutional trial, ARST0332, to investigate a riskbased strategy for the treatment of patients younger than 30 years old with nonrhabdomyosarcoma soft-tissue sarcomas. A total of 551 eligible patients were enrolled including 25 subjects with ASPS. Although there is an abundance of information in the literature regarding the pathologic and clinical features of ASPS, little has been published regarding its imaging features. The ARST0332 study afforded us the opportunity to review the imaging features of ASPS in a relatively large cohort of prospectively enrolled young patients. Therefore, the purpose of this study was to perform a comprehensive review of the imaging features of ASPS and, when possible, to correlate the imaging features with the pathologic findings. The goal of the study was to improve our understanding of the imaging features of this rare tumor and to identify imaging findings that might suggest the diagnosis to radiologists in their everyday practice.
Materials and Methods
The study cohort was composed of patients with ASPS who were younger than 30 years old and were enrolled in COG protocol ARST0332 between February 2007 and February 2012. The protocol was HIPAA-compliant and approved by the institutional review boards at the participating institutions; all subjects or their guardians signed informed consent or assent as appropriate. The tumors of all patients were centrally reviewed by two pathologists with expertise in pediatric soft-tissue tumors to confirm the histologic subtype of nonrhabdomyosarcoma soft-tissue sarcoma. These pathologists confirmed the diagnosis of ASPS by performing reviews of the local pathology reports and histologic inspections of the biopsy specimens. Additional supporting immunohistochemical or genomic testing for ASPS was performed at the discretion of the local institution but was not required for central review. Because we sought to correlate imaging findings with gross pathologic findings of ASPS, the study pathologists collected information regarding gross tumor pathology from local pathology reports.
Subjects underwent either CT or MRI of the primary tumor and chest CT and nuclear medicine studies for staging at their local institution. Imaging examinations were sent prospectively to the Quality Assurance Review Center (QARC) in Lincoln, RI, where patient identifiers were removed and unique identifiers were assigned. The imaging studies with patient identifiers removed were reviewed by two central radiologist reviewers with 25 and 12 years of faculty-level experience in pediatric radiology at the beginning of the study period. Both radiologists independently determined tumor measurements in 3D and assessed for neurovascular and bone involvement. Neurovascular involvement was categorized as follows: tumor not abutting the neurovascular bundle, tumor abutting the neurovascular bundle, or tumor surrounding the neurovascular bundle. Bone involvement was categorized as follows: tumor not abutting bone, tumor abutting bone, or tumor destroying bone. Discrepancies were resolved by consensus between the two radiologists. The prospectively collected imaging data and the demographic and clinical features assessed at study entry were obtained from the COG database for the purposes of the current study.
Imaging Review
For the purposes of this study, the MRI and CT examinations of the ASPS primary tumors that were also recorded. When the "split-fat" sign (i.e., fat surrounding the poles of an intramuscular tumor) was present, the tumor origin was considered indeterminate. When applicable, the same parameters were assessed on axial, sagittal, and coronal CT images. All cases but one were reviewed at a PACS (Syngo workstation, Siemens Healthcare), and the workstation tools (e.g., window, level, magnification) were used at each reviewer's discretion. The images for one case were available only as hard-copy films.
Results

Demographic Characteristics of Subjects and Anatomic Features of Tumors
Among the 25 enrolled subjects with ASPS, three were excluded because preoperative imaging was not available. Prether- 
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apy imaging studies for the remaining 22 subjects were obtained from 18 local institutions. MRI was available for 16 subjects, CT for three, and both MRI and CT for three. The demographics and clinical features of these 22 subjects are shown in Table 1 . On imaging, the maximum tumor diameters ranged from 2.3 cm for an orbital tumor to 20.0 cm for a retroperitoneal tumor (median maximum diameter, 5.9 cm). Fifteen tumors (15/22, 68%) measured 5 cm or larger in greatest dimension. Tumor volumes ranged from 869 mL for a thigh tumor to 2.9 mL for a hand tumor (median volume, 43.2 mL). Seventeen tumors arose from muscle, and five were of indeterminate origin (centered in muscle but had a split-fat sign). Seven tumors (7/22, 32%) abutted the neurovascular bundle, and one paraspinal tumor invaded a neural foramen and the spinal canal (1/22, 5%). Six tumors (6/22, 27%) abutted bone, and three (3/22, 14%) destroyed bone, one of which resulted in pathologic fracture (Fig.  1A) . Six tumors (6/22, 27%) showed evidence of central necrosis. The MR and CT features of these tumors are described in detail in the following sections.
MRI Features
The 19 tumors imaged with MRI were in the following sites: thigh (n = 8), chest wall (n = 2), upper arm (n = 2); calf (n = 2); and foot, forearm, hand, orbit, and paraspinal area (n = 1 each). Eighteen of the 19 MRI examinations included unenhanced imaging (T1-weighted, n = 18; T2-weighted, n = 17; STIR, n = 14), and 13 included contrastenhanced imaging; only contrast-enhanced imaging was performed in one subject. The MRI signal characteristics and enhancement patterns are summarized in Table 2 . Of these 19 tumors, flow voids were both central and peripheral in 18 (18/19, 95%; Fig. 2A ) and were only peripheral in one (1/19, 5%). Sixteen tumors (16/19, 84%) had large vessels emanating from the superior and inferior poles that converged toward the center of the tumor (Fig. 2A) . Fourteen of 18 tumors (14/18, 78%) imaged with an unenhanced T1-weighted sequence appeared slightly hyperintense to muscle (Fig. 2B) .
Eighteen tumors (18/19, 95%) had predominantly sharp margins, although 12 (12/18, 67%) of these had poorly defined margins at the superior and inferior poles where large vessels were present (Fig. 3) . One paraspinal tumor infiltrated a neural foramen, one orbital tumor had poorly defined margins, and 4 and 5B), and 16 also had a nodular internal architecture, with nodules that were separated by thin hypodense bands on T1-weighted, T2-weighted, or STIR images (Figs. 2B, 4, and 5B). The degree of enhancement was intense in nine tumors (9/13, 69%; Fig. 5C ) and moderate in four (4/13, 31%; Fig. 2C ). Of the four tumors with peripheral enhancement, all showed a thick peripheral enhancing rim surrounding a central low-signal-intensity area consistent with central necrosis (Fig. 6A) . Fourteen tumors (14/19, 74%) had target lesions that were peripherally bright and centrally dark on T2-weighted images (Figs. 4 and 5B).
CT Features
Six tumors were imaged with contrast-enhanced CT: two chest wall-breast tumors, one pelvic tumor, one abdominal wall tumor, one thigh tumor, and one thoracic paraspinal muscle tumor. All six had prominent vessels located at the superior and inferior poles of the tumor. In one case, large tumor vessels were thrombosed (Figs. 7A and 7B). Four tumors had predominantly sharp margins; however, two of these had infiltrative margins in the area of the vessels. Two tumors had predominantly infiltrative margins. Therefore, four (4/6, 67%) had at least partially infiltrative margins. Five tumors had lobulated margins, all six had nodular internal architecture, and all six had small rimenhancing target lesions (Fig. 1B) . All six tumors enhanced, with five (5/6, 83%) showing intense enhancement and one, moderate. Three tumors showed evidence of central necrosis on CT; one of these three tumors was also imaged with MRI and had MR evidence of central necrosis. Two of these three tumors had a thick peripheral rim of enhancement and no central enhancement (Fig.  6B) . The third, a very large thigh mass, had a nodular, thick, enhancing peripheral rim involving the majority of the tumor and imperceptible tumor margins elsewhere (Fig. 1A) . The combined MRI and CT features of all tumors are summarized in Table 3 .
Pathologic Review
The gross tumor specimens were not available for pathology review. Therefore, to assess the gross appearance of ASPS, we reviewed pathology reports, which were available for 15 excised tumors. The remaining seven tumors underwent delayed resection after neoadjuvant therapy; these tumors were diagnosed by incisional or needle biopsy. Of the 15 gross tumor specimens, all were described as circumscribed, firm, fleshy, nodular masses ranging in size from 0.5 to 7.0 cm (mean, 3.4 cm). Vascular invasion was evaluated in 10 specimens and was present in nine (9/10, 90%). Prominent vascularity was commented on in two reports. In one report, the pathologist noted that the tumor was being supplied by a "bleeder." Comments regarding tumor hemorrhage were made in six reports, and hemorrhage was present in three of these tumors. These three tumors, all of which were imaged using MRI only, did not have evidence of hemorrhage on imaging. The presence or absence of necrosis was commented on in four reports, and cen- 
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tral necrosis was documented in one tumor. This latter tumor showed evidence of necrosis on both MRI and CT.
Discussion
Because of the rarity of ASPS, only case reports and small case series describing the imaging features of this tumor are available in the literature. The COG ARST0332 multiinstitutional trial for the treatment of nonrhabdomyosarcoma soft-tissue sarcomas gave us the opportunity to more comprehensively assess the imaging features of this rare tumor in a relatively large cohort of young patients. When the clinicopathologic features of ASPS were initially described in 1952, Christopherson and colleagues [9] noted that:
the most striking feature of the alveolar soft-part sarcoma is the basic uniformity throughout a given tumor and the similarity of one tumor to another.
We also found that these tumors appear strikingly similar to one another on imaging and that they have unique imaging features that should suggest the diagnosis.
The most consistent imaging feature of the ASPS tumors in our study was the presence of intra-and peritumoral vessels. All 19 tumors imaged with MRI had flow voids consistent with high-flow vessels; in 18 tumors (18/19, 95%), flow voids were present at both the periphery and center of the tumor. This MR finding has been reported to be a feature of ASPS tumors and, as in our study, has been described to be present at both the periphery and center of the tumor [12] [13] [14] [15] [16] [17] . The majority of the tumors in our study (19/22 , 86%) also had large vessels at the superior and inferior poles that were evident on MRI and CT and, similar to the recent report by Viry and colleagues [12] , that seemed to converge toward the center of the tumor. These features are also consistent with the imaging findings reported by others who noted the highly vascular nature of ASPS on imaging studies [8, [12] [13] [14] [16] [17] [18] . Several investigators who reported the conventional angiographic findings of ASPS described similar findings on angiography [14] [15] [16] . This hypervascular tumor shows numerous enlarged vessels with arteriovenous shunting in the arterial phase followed by intense tumor staining. Despite the rapid shunting of blood, washout of contrast material from the lesion is slow [14] [15] [16] [17] . This somewhat stagnant venous drainage may partially explain the presence of thrombosed tumor vessels in a large pelvic tumor in our series. Alternatively, these thrombi could have been caused by direct vascular invasion by tumor, which was a common pathologic feature of tumors (9/10, 90%) in our series. In contrast to others who have reported intense enhancement of all ASPS tumors on MRI or CT [8, 12, 15, 16] , we found that 31% of tumors showed only moderate enhancement. Importantly, no tumor in our study showed minimal enhancement or a complete lack of enhancement. This difference between our results and others could be because of our larger sample size and the subjective nature of assessing the degree of contrast enhancement on imaging studies.
Consistent with prior reports, we found that ASPS is either isointense or, more commonly, slightly hyperintense to muscle on T1-weighted MR images [8, 12, 15, 16] . This unique feature is in contrast to the majority of pediatric soft-tissue sarcomas, which appear hypointense on T1-weighted images [19] . The cause of this finding is unclear, but tumor hyperintensity has been postulated to result from either the effect of chemotherapy or slow capillary blood flow within the tumor [12, 15, 16] . Because all tumors in our study were imaged before the initiation of chemotherapy, chemotherapy can be excluded as a cause of this finding in our cohort. Other tumors that may ap- 
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pear hyperintense on T1-weighted MRI are hemangioma, clear cell sarcoma, melanoma, and hemorrhagic soft-tissue tumors including the most common soft-tissue sarcoma in children, rhabdomyosarcoma. Clear cell sarcoma and melanoma appear hyperintense on T1-weighted images when melanocytic differentiation is present. However, unlike ASPS, these tumors lack flow voids. The fibrofatty component of hemangiomas may appear hyperintense on T1-weighted images, and this tumor may contain flow voids. However, hemangiomas lack the large tumor vessels typical of ASPS, do not become centrally necrotic (as we found in 27% of our cases), and occur in a younger age group [20] . Although hemorrhage in other soft-tissue tumors, such as rhabdomyosarcoma, may appear hyperintense on T1-weighted images (depending on the age of blood products), the nonhemorrhagic, solid component of most pediatric soft-tissue malignancies will remain hypointense on this MR sequence in contrast to ASPS, which is typically slightly hyperintense [19] . It is interesting that three tumors in our series showed pathologic evidence of hemorrhage that was not visible on MRI. It is possible that the hemorrhage in these tumors occurred after the imaging was performed, but we are unable to validate this possible explanation.
We identified several additional imaging features that have not been previously reported for ASPS. Intra-and peritumoral target lesions that were small, peripherally bright, and centrally dark on T2-weighted MR images or that showed a rim of peripheral enhancement on CT were a common finding in our study and are consistent with the presence of numerous small tumor vessels. The target sign has been described as being nearly pathognomonic of peripheral nerve sheath tumors and is attributed to central fibrosis and collagen, resulting in low signal intensity on T2-weighted imaging, and peripheral myxoid tissue, producing high signal intensity [21] [22] [23] . However, target lesions associated with peripheral nerve sheath tumors tend to be larger and more variable in size in contrast to the target lesions seen in our study, which were small and uniform. Additionally, neurogenic tumors lack prominent vessels that are seen with ASPS, a feature that should be useful in differentiating these tumors from ASPS tumors.
The majority of tumors in our study had lobulated margins (86%) and a nodular internal architecture (86%). Tumor nodules were separated by thin dark bands of tissue on water-sensitive MR sequences. These bands might be the fibrovascular septa seen on histopathologic inspection that separate the pseudoalveolar or organoid arrangement of tumor cells [9, 24] . We also found that most tumors had sharply defined margins except at the poles where large tumor vessels were present. We speculate that this finding may be a reflection of peritumoral edema or direct tumor spread. Interestingly, all 15 tumors that underwent gross pathologic inspection in our study were described as nodular and circumscribed. We also found that, when present, necrosis was always central in location and surrounded by a thick rim of enhancing viable tumor. Because tumor vessels seem to course toward the center of tumors, we speculate that the highly vascularized central core becomes necrotic as a result of tumor vascular invasion that begins centrally and progresses to the periphery. Alternatively, this appearance could be the result of stagnant blood flow or central hypoxia as the tumor outgrows its vascular supply. In the future, prospective studies that directly correlate the imaging and anatomic and microscopic pathologic features of ASPS will allow a better understanding of the imaging features of this unique tumor.
The histogenic origin of ASPS remains uncertain, but a myogenic or neural crest origin has been suggested [8] . Although analysis of histochemical markers supports a myogenic theory [25] , a study of the immunocytochemistry and biochemistry of 12 ASPS tumors found that none was positive for myoglobin or muscle actin and none expressed nuclear MyoD1 or myogenin [26] . The majority of tumors in our study appeared to arise from muscle, but five exhibited the split-fat sign, which is known to be associated with neurogenic tumors that arise between muscles [21, 27] . Although ASPS is typically described as a well-circumscribed tumor, several tumors in our study infiltrated adjacent structures: a neural foramen in one case and between metatarsals in another. An additional three tumors directly invaded bone, a finding that has been reported by others and illustrates the highly aggressive nature of this tumor [15, 17] . 
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Our study has several limitations. Because imaging was performed at 18 different institutions, there was some variability in image quality and in the MR sequences that were performed. However, all images were of sufficient quality to allow accurate assessment of the imaging features of the tumors. Although our sample size is relatively large given the rarity of this tumor, the sample size does remain moderate at best. Also, for practical reasons, the ARST0332 protocol did not require central review of gross pathology specimens. Therefore, our assessment of the anatomic pathologic features of the tumors was based on the pathology reports rather than a review of the pathologic specimens. Thus, we were unable to directly correlate imaging features with pathologic findings for many of the tumors in our series.
In conclusion, despite the rarity of ASPS, we have reviewed the MRI and CT features of a relatively large cohort. This review has allowed us to perform a more comprehensive assessment of the imaging features of ASPS than has been possible previously. Our findings are in agreement with others who have described the extremely vascular nature of this tumor. A diagnosis of ASPS should be considered when a solid tumor arising in muscle is slightly hyperintense to muscle on unenhanced T1-weighted MR images, contains flow voids, has large vessels at the poles, and shows moderate to intense contrast enhancement. Additional features of ASPS that we identified and that have not been previously reported are the presence of small target lesions and a nodular internal architecture. Tumor margins tend to be lobulated and sharply defined except in areas where vessels are present. When necrosis is present, it is located centrally and surrounded by a thick rim of enhancing solid tumor. In the future, a direct correlation between the imaging features and the anatomic pathologic findings will further our understanding of the imaging appearance of this rare and unique tumor.
